Bibliography
- ASHORN PA, BERGER EA, MOSS B: Human immunodeficiency virus envelope glycoprotein/CD4-mediated fu- sion of non-primate cells with human cell. J. Virol. (1990) 64:2149–2156.
- MADDON PJ, DALGEISH AG, MCDOUGAL JS eta].: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and brain. Cell (1986) 47:333–385.
- SCHUITEMAKER H, KOOTSTRA NA, GOEDE REYD et al: Monocytotropic human immunodeficiency virus type-1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-induc- ing ability in primary T-cell culture. J. Virol. (1991) 65:356–363.
- BERSON JF, LONG D, DORANZ BJ et al.: A seven trans- membrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains. J. Virol. (1996) 70:6288–6295.
- CHOE H, FARZAN M, SUN Y et aL: The I3-chemokine receptors CCR3 and CCR5 facilitate infection by pri- mary HIV-1 isolates. Cell (1996) 85:1135–1148.
- DENG HK, LIU R, ELLMEIER W et aL: Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 381:661–666.
- DORANZ BJ, RUCKER J, YI YJ eta].: A dual-tropic primary HIV-1 isolate that uses fusin and the I3-chemokine re-ceptors CKR-5, CKR-3, and CKR-2b as fusion co-factors. Cell (1996) 85:1149–1158.
- DRAGIC T, LIT WIN V, ALLAWAY GP etal: HIV-1 entity into CD4 + cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 381:667–673.
- FENG Y, BRODER CC, KENNEDY PE, BERGER EA: HIV-1 entry co-factor: functional cDNA cloning of a seven transmembrane domain G-protein coupled receptor. Science (1996) 272:872–877.
- TERSMETTE M, GOEDE REYD, Al BJM eta].: Differential syncytium-inducing capacity of human immunodefi-ciency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. (1988) 62:2026–2032.
- ZHANG L, HUANG Y, HE T, CAO Y, HOD: HIV-1 subtype and second-receptor use. Nature (1996) 383:768.
- BRODER CC, DIMITROV DS, BLUMENTHAL R, BERGER EA: The block to HIV-1 glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology (1993) 193:483–491.
- DRAGIC T, CHARNEAU P, CLAVEL F, ALIZON M: Comple- mentation of murine cells for human immunodefi-ciency virus envelope/CD4-mediated fusion in murine/human heterokaryons. j Virol. (1992) 66:4794–4802.
- COCCHI F, DEVICO AL, GARZINO-DEMO A eta].: Identifi- cation of RANTES, MIP-la and MIP-1I3 as the major HIV-suppressive factors produced by CD8 1- T-cells. Sci-ence (1995) 270:1811–1815.
- COCCHI F, DEVICO AL, GARZINO-DEMO A eta].: The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature Med. (1996) 2:1244–1247.
- TRKOLA A, DRAGIC T, ARTHOS J eta].: CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature (1996) 384:184–187.
- WU LJ, GERARD NP, WYATT R et al.: CD4-induced inter- action of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 384:179–183.
- MOORE JP: Co-receptors: implications for HIV patho- genesis and therapy. Science (1997) 276:51–52.
- ATCHISON RE, GOSLING J, MONTECLARO FS eta].: Multi- ple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science (1996) 274:1924–1926.
- RUCKER J, SAMSON M, DORANZ BJ et al.: Regions in I3-chemokine receptors CCR5 and CCR2b that deter- mine HIV-1 co-factor specificity. Cell (1996) 87:437–446.
- CARR CM, KIM PS: Flu virus invasion: halfway there. Science (1994) 266:234–236.
- WEISS RA: Cellular receptors and viral glycoproteins involved in viral entry. In: The Retroviridae. Levy JA (Ed.), Plenum Press, New York (1993):1–108.
- ENDRES MJ, CLAPHAM PR, MARSH M et al.: CD4-inde- pendent infection by HIV-2 is mediated by Fusin/CXCR4. Cell (1996) 87:745–756.
- ARENZANA-SEISDEDOS F, VIRELIZIER JL, ROUSSET D eta].: HIV blocked by chemokine antagonist. Nature (1996) 383:400.
- SIMMONS G, CLAPHAM PR, PICARD L et al.: Potent inhi- bition of HIV-1 infectivity in macrophages and lympho- cytes by a novel CCR5 antagonist. Science (1997) 276:276–279.
- DEAN M, CARRINGTON M, WINKLER C et al Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemo-philia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study [see comments]. Science (1996) 273:1856–1862.
- SAMSON M, LIBERT F, DORANZ BJ et al.: Resistance toHIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 382:722–725.
- HUANG Y, PAXTON WA, WOLINSKY SM eta].: The role ofa mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. (1996) 2:1240–1243.
- LIU R, PAXTON WA, CHOE S eta].: Homozygous defect inHIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell (1996) 86:367–377.
- BITI R, FFRENCH R, YOUNG J, BENNETTS B, STEWART G:HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med. (1997) 3:252–253.
- KERR RA: Exploiting the HIV-chemokine nexus. Science (1997) 31:1261–1265.